Hospital-Acquired and Ventilator-Associated Pneumonia

Catia Cillóniz; Cristina Dominedo; Adrian Ceccato; Antoni Torres

doi:10.1016/B978-0-08-102723-3.00176-1

Hospital-Acquired and Ventilator-Associated Pneumonia

Catia Cillóniz, Cristina Dominedo, Adrian Ceccato, Antoni Torres

Producción científica: Libro o Capítulo del libro › Capítulo de Libro › revisión exhaustiva

Resumen

Hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) are, together, a major cause of morbidity and mortality despite improvements in their management. Their incidences remain high worldwide and, alongside the increased spread of multidrug-resistant organisms, have become a challenge for physicians and a global public health problem. New results published in the last decade as well as the emergence of new technologies have changed our understanding of the pathophysiology of pneumonia, providing knowledge that can be used to develop new treatments and prevent HAP/VAP.

Idioma original	Inglés estadounidense
Título de la publicación alojada	Encyclopedia of Respiratory Medicine, Second Edition
Editorial	Elsevier
Páginas	206-219
-	14
Volumen	4
ISBN (versión digital)	9780081027240
ISBN (versión impresa)	9780081027233
DOI	https://doi.org/10.1016/B978-0-08-102723-3.00176-1
Estado	Indizado - 1 ene. 2021
Publicado de forma externa	Sí

Nota bibliográfica

Publisher Copyright:
© 2022 Elsevier Ltd. All rights reserved

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

Acceder al documento

10.1016/B978-0-08-102723-3.00176-1

Citar esto

@inbook{7122afeff8d34debb7d4fb021f0728f8,

title = "Hospital-Acquired and Ventilator-Associated Pneumonia",

abstract = "Hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) are, together, a major cause of morbidity and mortality despite improvements in their management. Their incidences remain high worldwide and, alongside the increased spread of multidrug-resistant organisms, have become a challenge for physicians and a global public health problem. New results published in the last decade as well as the emergence of new technologies have changed our understanding of the pathophysiology of pneumonia, providing knowledge that can be used to develop new treatments and prevent HAP/VAP.",

keywords = "Antimicrobial resistance, Hospital-acquired pneumonia, Infection, Nosocomial pneumonia, Pneumonia, Respiratory infection, Ventilator-associated pneumonia",

author = "Catia Cill{\'o}niz and Cristina Dominedo and Adrian Ceccato and Antoni Torres",

year = "2021",

month = jan,

day = "1",

doi = "10.1016/B978-0-08-102723-3.00176-1",

language = "American English",

isbn = "9780081027233",

volume = "4",

pages = "206--219",

booktitle = "Encyclopedia of Respiratory Medicine, Second Edition",

publisher = "Elsevier",

address = "Netherlands",

}

TY - CHAP

T1 - Hospital-Acquired and Ventilator-Associated Pneumonia

AU - Cillóniz, Catia

AU - Dominedo, Cristina

AU - Ceccato, Adrian

AU - Torres, Antoni

PY - 2021/1/1

Y1 - 2021/1/1

N2 - Hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) are, together, a major cause of morbidity and mortality despite improvements in their management. Their incidences remain high worldwide and, alongside the increased spread of multidrug-resistant organisms, have become a challenge for physicians and a global public health problem. New results published in the last decade as well as the emergence of new technologies have changed our understanding of the pathophysiology of pneumonia, providing knowledge that can be used to develop new treatments and prevent HAP/VAP.

AB - Hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) are, together, a major cause of morbidity and mortality despite improvements in their management. Their incidences remain high worldwide and, alongside the increased spread of multidrug-resistant organisms, have become a challenge for physicians and a global public health problem. New results published in the last decade as well as the emergence of new technologies have changed our understanding of the pathophysiology of pneumonia, providing knowledge that can be used to develop new treatments and prevent HAP/VAP.

KW - Antimicrobial resistance

KW - Hospital-acquired pneumonia

KW - Infection

KW - Nosocomial pneumonia

KW - Pneumonia

KW - Respiratory infection

KW - Ventilator-associated pneumonia

UR - http://www.scopus.com/inward/record.url?scp=85143089824&partnerID=8YFLogxK

U2 - 10.1016/B978-0-08-102723-3.00176-1

DO - 10.1016/B978-0-08-102723-3.00176-1

M3 - Chapter

AN - SCOPUS:85143089824

SN - 9780081027233

VL - 4

SP - 206

EP - 219

BT - Encyclopedia of Respiratory Medicine, Second Edition

PB - Elsevier

ER -

Hospital-Acquired and Ventilator-Associated Pneumonia

Resumen

Nota bibliográfica

ODS de las Naciones Unidas

Acceder al documento

Huella

Citar esto